UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 149 filers reported holding KURA ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q2 2024$2,575,891
+39.3%
125,104
+44.4%
0.00%0.0%
Q1 2024$1,848,587
+57.0%
86,666
+5.9%
0.00%
Q4 2023$1,177,089
+57.7%
81,8560.0%0.00%
Q3 2023$746,527
+52.7%
81,856
+104.8%
0.00%
Q2 2023$488,8220.0%39,9690.0%0.00%
Q1 2023$488,822
-14.2%
39,969
-13.0%
0.00%
Q4 2022$569,855
-99.9%
45,9190.0%0.00%
Q3 2022$627,253,000
-89.9%
45,919
-86.5%
0.00%
-100.0%
Q2 2022$6,240,670,000
+10.7%
340,462
-2.9%
0.00%
+50.0%
Q1 2022$5,636,537,000
+8.3%
350,531
-5.7%
0.00%0.0%
Q4 2021$5,204,500,000
-27.5%
371,750
-3.0%
0.00%
-33.3%
Q3 2021$7,176,120,000
-12.3%
383,135
-2.4%
0.00%
-25.0%
Q2 2021$8,187,024,000
-3.5%
392,663
+30.9%
0.00%0.0%
Q1 2021$8,480,321,000
+0.1%
299,976
+15.7%
0.00%0.0%
Q4 2020$8,469,260,000
+614.2%
259,316
+570.1%
0.00%
+300.0%
Q3 2020$1,185,768,000
+90.2%
38,700
+1.2%
0.00%
Q2 2020$623,311,000
+303.7%
38,240
+146.5%
0.00%
Q1 2020$154,385,000
-52.8%
15,516
-34.8%
0.00%
Q4 2019$327,155,000
-8.9%
23,793
+0.5%
0.00%
Q3 2019$359,104,00023,6720.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,849,947$25,899,0005.33%
Asymmetry Capital Management, L.P. 502,275$7,032,0003.73%
Affinity Asset Advisors, LLC 560,000$7,840,0002.85%
Deep Track Capital, LP 2,550,000$35,700,0002.52%
ACUTA CAPITAL PARTNERS, LLC 291,884$4,086,0001.72%
EcoR1 Capital, LLC 3,724,437$52,142,0001.66%
SPHERA FUNDS MANAGEMENT LTD. 832,238$11,651,0001.28%
Ghost Tree Capital, LLC 225,000$3,150,0001.13%
BVF INC/IL 2,064,212$28,899,0001.05%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,513,756$49,193,0001.03%
View complete list of KURA ONCOLOGY INC shareholders